QT Imaging Holdings, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $38.2M
- Price
- $2.61
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.25%
- Volume
- 33.0K
About
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
Quick stats
Shares outstanding14.6M
Computed float8.1M
Float / shares55.1%
Cash runway (months)5.3
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001844505
Websitehttps://www.qtimaging.com
AI Summary
AI-generated1/30
minorbullishregulatory
QT Imaging Announces CPT® Category III Code for 3D Breast Acoustic Imaging Now Effective
QT Imaging announced that CPT Category III code 1079T for its 3D breast acoustic imaging technology became effective October 1, 2026, three months earlier than anticipated.
The dedicated code lets providers report the breast imaging service and allows QT Imaging to immediately advance implementation efforts with imaging centers, physicians, and payers.
CMS's October 2026 Medicare Physician Fee Schedule Database update confirms 1079T with an October 1 record effective date, a step in building the reimbursement infrastructure for broader commercial adoption.
Red flags
- Category III CPT codes are tracking codes and do not guarantee Medicare or commercial payment rates
- Company discloses an identified material weakness in internal controls over financial reporting in forward-looking statement risk factors